Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5075772

CCCCCCCCCCCCCCCCCCNCCC[Si](O)(O)O.Cl

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 known ✓ O95136 5/20 0.47
S1PR4 known ✓ O95977 5/20 0.47
S1PR1 known ✓ P21453 5/20 0.47
S1PR3 known ✓ Q99500 5/20 0.47
S1PR5 known ✓ Q9H228 1/20 0.47
CA2 known ✓ P00918 1/20 0.39
ALDH1A1 P00352 1/20 0.56
TSHR P16473 1/20 0.56
EPHX1 P07099 8/20 0.45
GNAI3 P08754 1/20 0.42
GNAO1 P09471 1/20 0.42
GNAI1 P63096 1/20 0.42
ADH1B P00325 1/20 0.41
ADH1C P00326 1/20 0.41
ADH1A P07327 1/20 0.41
ADH4 P08319 1/20 0.41
ADH7 P40394 1/20 0.41
PAOX Q6QHF9 1/20 0.41
CASP2 P42575 1/20 0.41
CA1 P00915 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29613170 0.98 ALDH1A1 (0.54) ALDH1A1TSHRS1PR2S1PR4S1PR1
SCHEMBL5453404 0.98 ALDH1A1 (0.59) ALDH1A1TSHRS1PR2S1PR4S1PR1
SCHEMBL4525088 0.93 ALDH1A1 (0.59) ALDH1A1TSHRS1PR2S1PR4S1PR1
Hydrochloric Acid SCHEMBL2297763 0.92 ALDH1A1 (0.46) ALDH1A1TSHRS1PR2S1PR4S1PR1
SCHEMBL4514592 0.89 ALDH1A1 (0.59) ALDH1A1TSHRS1PR2S1PR4S1PR1
SCHEMBL4536296 0.89 ALDH1A1 (0.59) ALDH1A1TSHRS1PR2S1PR4S1PR1
SCHEMBL4528133 0.89 ALDH1A1 (0.59) ALDH1A1TSHRS1PR2S1PR4S1PR1
SCHEMBL4529119 0.89 ALDH1A1 (0.59) ALDH1A1TSHRS1PR2S1PR4S1PR1
SCHEMBL2520182 0.89 TSHR (0.50) ALDH1A1TSHRS1PR2S1PR4S1PR1
SCHEMBL4533464 0.86 TSHR (0.62) ALDH1A1TSHRS1PR2S1PR4S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1887863-A2 METHODS AND COMPOSITIONS FOR BIOCIDAL TREATMENTS SiShield Technologies (US) 2008-02-20 EP claimed
US-20070065475-A1 Methods and compositions for antimicrobial surfaces TERMPRO, LLC 2007-03-22 US claimed
US-20060193816-A1 Methods and compositions for biocidal treatments TERMPRO, LLC 2006-08-31 US claimed
WO-2006086271-A2 METHODS AND COMPOSITIONS FOR BIOCIDAL TREATMENTS ELFERSY JACQUES (US) 2006-08-17 WO claimed
US-8999363-B2 Methods and compositions for antimicrobial surfaces SISHIELD TECHNOLOGIES, INC. (US) 2015-04-07 US disclosed
US-8999357-B2 Methods and compositions for biocidal treatments SISHIELD TECHNOLOGIES, INC. (US) 2015-04-07 US disclosed
EP-1887863-A2 METHODS AND COMPOSITIONS FOR BIOCIDAL TREATMENTS SiShield Technologies (US) 2008-02-20 EP disclosed
US-20070065475-A1 Methods and compositions for antimicrobial surfaces TERMPRO, LLC 2007-03-22 US disclosed
US-20060193816-A1 Methods and compositions for biocidal treatments TERMPRO, LLC 2006-08-31 US disclosed
WO-2006086271-A2 METHODS AND COMPOSITIONS FOR BIOCIDAL TREATMENTS ELFERSY JACQUES (US) 2006-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060193816-A1 Methods and compositions for biocidal treatments PIK3C3, TET2, CUTA S1PR2 4548/4885S1PR4 4573/4885S1PR1 4453/4885
US-20070065475-A1 Methods and compositions for antimicrobial surfaces SIGLEC7, EPCAM, BSG S1PR2 2169/4885S1PR4 1379/4885S1PR1 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.